Inhibition of Tumor Promotion in Mouse Skin by 1α,25-Dihydroxyvitamin D3

Cancer Research

Volumn 45, Issue , 1985, Pages 5426-5430

  Chida, Kazuhiro ^a   Kuroki, Toshio ^b   Fukushima, Masafumi ^a   Suda, Tatsuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CALCITRIOL; COLECALCIFEROL; MEZEREIN; ORNITHINE C 14; ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE; RADIOISOTOPE; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CARCINOGENESIS; DRUG ANTAGONISM; DRUG EFFICACY; HYPERCALCEMIA; INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; TOPICAL DRUG ADMINISTRATION;

ANIMALS; CALCITRIOL; CALCIUM; ENZYME INDUCTION; FEMALE; MICE; ORNITHINE DECARBOXYLASE; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 0022392919     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. DeLuca, H. F., and Schnoes, H. K. Metabolism and mechanism of action of vitamin D. Armu. Rev. Biochem., 45: 631-642, 1976.
2. Kuroki, T., Chida, K., Hashiba, H. (Hosoi, J., Hosomi, J., Sasaki, K., Abe, E., and Suda, T. Regulation of ceil differentiation and tumor promotion by 1a, 25-dihydroxyvitamin Ds. In: E. Huberman (ed.), The Role of Chemicals and Radiation in the Etiology of Cancer, The Argonne International Symposium. New York: Raven Press, in press, 1985.
3. Abe, E., Shllna, Y., Miyaura, C., Tanaka, H., Hayashi, T., Kanegasaki, S., Saito, M., Nishll, Y., DeLuca, H. F., and Suda, T. Activation and fusion induced by 1a, 25-dihydroxyvitamin D3 and their relation in alveolar macrophages. Proc. Natl. Acad. Sci. USA, 87: 7112-7116, 1984.
4. Abe, E., Miyaura, C., Sakagami, H., Takada, M., Konno, K., Yamazaki, T., Yoshiki, S., and Suda, T. Differentiation of mouse myeloid leukemia cells induced by 1a, 25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA, 78: 4990-4994, 1981.
5. Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., Konno, K., Nishü, Y., and Suda, T. 1a, 25-Dihydroxycholecalcfferol and a human myeloid leukemia cell line (HL-60). The presence of receptors and induction of differentiation. Biochem. J., 204: 713-719, 1982.
6. Otsson, I., Gutlberg, U., Ivhed, I., and Nilsson, K. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1a, 25-dihydroxycholecal-ciferol. Cancer Res., 43: 5862-5867, 1983.
7. Suda, S., Enomoto, S., Abe, E., and Suda, T. Inhibition by 1a, 25-dihydroxyvitamin Ds of dimethyl sulfoxide-induced differentiation of Friend aythroteukemia cells. Biochem. Biophys. Res. Commun., 119: 807-813, 1984.
8. Hosomi, J., Hosoi, J., Abe, E., Suda, T., and Kuroki, T. Regulation of terminal differentiation of cultured mouse epidermal cells by 1a, 25-dihydroxyvitamin D3. Endocrinology, 113: 1950-1957, 1983.
9. Hosoi, J., Abe, E., Suda, T., and Kuroki, T. Regulation of melanin synthesis of B16 mouse melanoma cells by 1a, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res., 45: 1474-1478, 1985.
10. Kuroki, T., and Suda, T. Similarity and dissimilarity between phorbol ester tumor promoters and 1a, 25-dihydroxyvitamin Ds, an active form of vitamin D3. In: H. Fujiki ef a/, (eds.), Cellular Interactions by Environmental Tumor Promoters, pp. 89-99. Tokyo: Japan Scientific Societies Press/Utrecht, The Netherlands: VNU Science Press, 1984.
11. Kuroki, T., Sasaki, K., Chida, K., Abe, E., and Suda, T. 1a, 25-Dihydroxyvitamin Ds markedly enhances chemically-induced transformation in BALB 3T3 cells. Gann, 74: 611-614, 1983.
12. Jones, C. A., Calaham, M. F., and Huberman, E. Enhancement of chemical-carcinogen-induced cell transformation in hamster embryo cells by 1a, 25-dihydroxycholecalcfferol, the biotogicaly active metabolite of vitamin D3. Carcinogenesis (Lond.), 5: 1155-1159, 1984.
13. Chida, K., Hashiba, H., Suda, T., and Kuroki, T. Inhibition by 1a, 25-dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12-0-tetfadecaroylphcfbol-13-acetate and telecddin, B. Cancer Res., 44: 1387-1391 1984.
14. Wood, A. W., Chang, R. L., Huang, M.-T., Uskokovic, M., and Conney, A. H. 1a, 25-Dihydroxyvitamin Ds inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. Biochem. Biophys. Res. Commun., 116: 605-611, 1983.
15. DiGiovanni, J., Slaga, T. J., and Boutwell, R. K. Comparison of the tumor-initiating activity of 7. 12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CD-1 mice. Carcinogenesis (Lond.), 7: 381-389, 1980.
16. Slaga, T. J., Fischer, S. M., Nelson, K., and Gteason, G. L. Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proc. Natl. Acad. Sci. USA, 77: 3659-3663, 1980.
17. Cormerty, H. V., and Briggs, A. R. Determination of serum calcium by means of orthocresolphthalein complexone. Am. J. Clin. Pathol., 45: 290-296, 1966.
18. Chida, K., and Kuroki, T. Inhibition of DNA synthesis and sugar uptake and lack of induction of ornithine decarboxylase in human epidermal cells treated with mouse skin tumor promoters. Cancer Res., 44: 875-879, 1984.
19. Bradford, M. M. A rapid and sensitive method for the quantitation of rrricrogram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
20. Kuroki, T. Possible functions of 1a, 25-dirtydroxyvitamin D3, an active form of vitamin Ds, in differentiation and development of skin. J. Invest. Dermatol., 84: 459-460, 1985.
21. Garland, C., Shekelle, R. B., Barrett-Connor, E., Criqui, M. H., Rossof, A. H., and Paul, O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet, 1: 307-309, 1985.
22. Slaga, T. J., Klein-Szanto, A. J. P., Fischer, S. M., Weeks, C. E., Nelson, K., and Major, S. Studies on the mechanism of action of antitumor-promoting agents: their specificity m two-stage promotion. Proc. Natl. Acad. Sci. USA, 77: 2251-2254, 1980.
23. Hicks, R. M. Pathological and biochemical aspects of tumor promotion. Carcinogenesis (Lond.), 4: 1209-1214, 1983.
24. O'Brien, T. G., Simsiman, R. C., and Boutwell, R. K. Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res., 35: 2426-2433, 1975.
25. Verma, A. K., Shapas, B. G., Rice, H. M., and Boutwell, R. K. Con-elation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res., 39: 419-425, 1979.
26. Takigawa, M., Verma, A. K., Simsiman, R. C., and Boutwell, R. K. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal potyamine biosynthesis by a-difuroomethylorrmithine. Cancer Res., 43: 3732-3738, 1983.
27. Kensler, T. W., Bush, D. M., and Kozumbo, W. J. Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science (Wash. DC), 227: 75-77, 1983.
28. Kozumbo, W. J., Seed, J. L., and Kensler, T. W. Inhibition by 2(3)-tert-butyl-4-hydroxyanisote and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-0-tetradecanolytphorbol-13-acetate. Cancer Res., 43: 2555-2559, 1983.
29. Slaga, T. J., Fischer, S. M., Weeks, C. E., Nelson, K., Mamrack, M., and Klein-Szanto, A. J. P. Specificity and mechanism(s) of promoter inhibitors in multistage promotion. In: E. Hecker, N. Fusenig, W. Kunz, F. Marks, and H. Thiefman (eds.), Carcinogenesis-a Comprehensive Survey, Vol. 7, pp. 19-34. New York: Raven Press, 1982.
30. Weekes, R. G., Verma, A. K., and Boutwell, R. K. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-0-tetradecajioylphorbol-13-acetate. Cancer Res., 40: 4013-4018, 1980.
31. Verma, A. K., Asbendel, C. L. and Boutwefl, R. K. Inhibition of prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-0-tetrade4canoylphorbol-13-acetate. Cancer Res., 40: 308-315, 1980.
32. Verma, A. K., Garcia, C. T., Ashendel, C. L., and Boutwel, R. K. Inhibition of 74-bromomethy1beriz(a)anthracene-poornoted mouse skin tumor formation by retinoic acid and dexamethasone. Cancer Res., 43: 3045-3049, 1983.